[1. ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation). Circulation. 2001;104: 2118-2150.10.1161/circ.104.17.2118]Search in Google Scholar
[2. Guidelines for the management of atrial fibrillation. European Heart Journal. 2010;31: 2369–2429.10.1093/eurheartj/ehq27820802247]Search in Google Scholar
[3. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Annals of Internal Medicine. 2007;146: 857-867.10.7326/0003-4819-146-12-200706190-0000717577005]Search in Google Scholar
[4. Camm AJ, Lip GY, De Caterina R et al. Focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. European Heart Journal. 2012;33:2719-2747.]Search in Google Scholar
[5. Pisters R, Lane DA, de Vos CB et al. A novel user-friendly score (HAS-BLED) to assess one-year risk of major bleeding in atrial fibrillation patients: The Euro Heart Survey. Chest. 2010;138(5):1093-1100.10.1378/chest.10-013420299623]Search in Google Scholar
[6. Thrift AG, Donnan GA, Mc Neil JJ. Epidemiology of intracranial hemorrhage. Epidemiologic Reviews. 1995;17:361-381.10.1093/oxfordjournals.epirev.a0361998654517]Search in Google Scholar
[7. Kase CS. Intracerebral hemorrhage. Baillière’s Clinical Neurology. 1995;4:247-278.]Search in Google Scholar
[8. Shorr RL, Ray WA, Daugherty JR et al. Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk of hemorrhagic peptic ulcer disease. Annals of Internal Medicine. 1993;153:1665-1670.10.1001/archinte.1993.00410140047006]Search in Google Scholar
[9. Eva Prescott, Rikke Sørensen. Female sex as a risk factor for stroke in atrial fibrillation. British Medical Journal. 2012;344:e3789.10.1136/bmj.e378922653983]Search in Google Scholar
[10. Avgil TM, Jackevicius CA, Rahme E et al. Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation. The Journal of the American Medical Association. 2012;307:1952-1958.10.1001/jama.2012.349022570463]Search in Google Scholar
[11. Dagres N, Nieuwlaat R, Vardas PE et al. Gender-related differences in presentation, treatment and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. Journal of the American College of Cardiology. 2007; 49:572-577.10.1016/j.jacc.2006.10.04717276181]Search in Google Scholar
[12. Flaherty MLKB, Woo D, Kleindorfer D et al. The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology. 2007;68:116-121.10.1212/01.wnl.0000250340.05202.8b17210891]Search in Google Scholar
[13. Geraint Fuller, Mark Manford. Neurology: An illustrated colour text, Churchill Livingstone Elsevier. Philadelphia. 2006;70-71.]Search in Google Scholar
[14. Sacco RL, Foulkes MA, Mohr JP et al. Determinants of early recurrence of cerebral infarction: the Stroke Data Bank. Stroke. 1989;20:983-989.10.1161/01.STR.20.8.983]Search in Google Scholar
[15. Sacco RL, Shi T, Zamanillo MC et al. Predictors of mortality and recurrence after hospitalised cerebral infarction in an urban community: the Northern Manhattan Stroke Study. Neurology. 1994;44:626-634.10.1212/WNL.44.4.626]Search in Google Scholar
[16. Hallas J, Dall M, Andersen BS et al. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study. British Medical Journal. 2006;333:726.10.1136/bmj.38947.697558.AE]Search in Google Scholar
[17. Sørensen R, Hansen ML, Abildstrom SZ et al. Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data. The Lancet. 2009;374:1967-1974.10.1016/S0140-6736(09)61751-7]Search in Google Scholar
[18. Saour JN, Sieck JO, Mamo LA et al. Trial of different intensities of anticoagulation in patients with prosthetic heart valves. New England Journal of Medicine. 1990;322:428-432.10.1056/NEJM199002153220703]Search in Google Scholar
[19. Palareti G, Leali N, Coccheri S et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. The Lancet. 1996;348:423-428.10.1016/S0140-6736(96)01109-9]Search in Google Scholar
[20. Hylek EM, Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Annals of Internal Medicine. 1994;120:897-902.10.7326/0003-4819-120-11-199406010-000018172435]Search in Google Scholar